Personal information

Germany

Activities

Employment (1)

Christian-Albrechts-Universität zu Kiel: Kiel, Schleswig-Holstein, DE

(Institut für Experimentelle Tumorforschung)
Employment
Source: Self-asserted source
Anna Trauzold

Works (50 of 72)

Items per page:
Page 1 of 2

Monocarboxylate Transporter-1 (MCT1)-Mediated Lactate Uptake Protects Pancreatic Adenocarcinoma Cells from Oxidative Stress during Glutamine Scarcity Thereby Promoting Resistance against Inhibitors of Glutamine Metabolism

Antioxidants
2023-09 | Journal article | Author
Contributors: Nourhane Ammar; Maya Hildebrandt; Claudia Geismann; Christian Röder; Timo Gemoll; Susanne Sebens; Anna Trauzold; Heiner Schäfer
Source: check_circle
Multidisciplinary Digital Publishing Institute

Synergistic effects of agonists and two-pore-domain potassium channels on secretory responses of human pancreatic duct cells Capan-1.

Pflugers Archiv : European journal of physiology
2022-12-19 | Journal article
Contributors: Sørensen CE; Trauzold A; Christensen NM; Tawfik D; Szczepanowski M; Ivana Novak
Source: Self-asserted source
Anna Trauzold

Endogenous TRAIL-R4 critically impacts apoptotic and non-apoptotic TRAIL-induced signaling in cancer cells.

Frontiers in cell and developmental biology
2022-09-09 | Journal article
Contributors: Rambow AC; Aschenbach I; Hagelund S; Doaa Tawfik; Gundlach JP; Weiße S; Maass N; Trauzold A
Source: Self-asserted source
Anna Trauzold

Impact of Extracellular pH on Apoptotic and Non-Apoptotic TRAIL-Induced Signaling in Pancreatic Ductal Adenocarcinoma Cells.

Frontiers in cell and developmental biology
2022-02-24 | Journal article
Contributors: Hagelund S; Trauzold A
Source: Self-asserted source
Anna Trauzold

TRAIL-receptor 2-a novel negative regulator of p53.

Cell death & disease
2021-07-31 | Journal article | Author
Contributors: Anna Willms; Schupp H; Poelker M; Adawy A; Debus JF; Hartwig T; Krichel T; Juergen Fritsch; Singh S; Walczak H et al.
Source: Self-asserted source
Anna Trauzold

Prognostic significance of high mobility group A2 (HMGA2) in pancreatic ductal adenocarcinoma: malignant functions of cytoplasmic HMGA2 expression.

Journal of cancer research and clinical oncology
2021-07-24 | Journal article
Contributors: Jan-Paul Gundlach; Hauser C; Schlegel FM; Willms A; Halske C; Röder C; Krüger S; Röcken; Becker T; Kalthoff H et al.
Source: Self-asserted source
Anna Trauzold

Engineering of CD19 Antibodies: A CD19-TRAIL Fusion Construct Specifically Induces Apoptosis in B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) Cells In Vivo.

Journal of clinical medicine
2021-06-15 | Journal article | Author
Contributors: Winterberg D; Lenk L; Oßwald M; Vogiatzi F; Gehlert CL; Frielitz FS; Klausz K; Rösner T; Thomas Valerius; Anna Trauzold et al.
Source: Self-asserted source
Anna Trauzold
grade
Preferred source (of 2)‎

Topology impacts TRAIL therapy: Differences in primary cancer growth and liver metastasis between orthotopic and subcutaneous xenotransplants of pancreatic ductal adenocarcinoma cells.

Hepatobiliary & pancreatic diseases international : HBPD INT
2021-04-26 | Journal article
Contributors: Kettler B; Trauzold A; Röder C; Egberts JH; Kalthoff H
Source: Self-asserted source
Anna Trauzold

Cytoplasmic levels of high mobility group A2 determine survival prognoses in breast cancer patients.

The International journal of biological markers
2020-05-12 | Journal article
Contributors: Heilmann T; Vondung F; Dr. phil. Dipl.-Psych. Christoph Borzikowsky; Krüger S; Elessawy M; Alkatout I; Wenners A; Bauer M; Klapper W; Röcken et al.
Source: Self-asserted source
Anna Trauzold

The A818-6 system as an in-vitro model for studying the role of the transportome in pancreatic cancer.

BMC cancer
2020-03-30 | Journal article
Contributors: Doaa Tawfik; Zaccagnino A; Bernt A; Szczepanowski M; Klapper W; Schwab A; Kalthoff H; Trauzold A
Source: Self-asserted source
Anna Trauzold

Dasatinib prevents skeletal metastasis of osteotropic MDA-MB-231 cells in a xenograft mouse model.

Archives of gynecology and obstetrics
2020-03-14 | Journal article
Contributors: Heilmann T; Rumpf AL; Roscher M; Tietgen M; Will O; Gerle M; Damm T; Dr. phil. Dipl.-Psych. Christoph Borzikowsky; Maass N; Glüer CC et al.
Source: Self-asserted source
Anna Trauzold

TRAIL-Receptor 4 Modulates γδ T Cell-Cytotoxicity Toward Cancer Cells.

Frontiers in immunology
2019-08-28 | Journal article
Contributors: Doaa Tawfik; Christopher Groth; Gundlach JP; Matthias Peipp; Kabelitz D; Becker T; Oberg HH; Trauzold A; Wesch D
Source: Self-asserted source
Anna Trauzold

TRAIL Induces Nuclear Translocation and Chromatin Localization of TRAIL Death Receptors.

Cancers
2019-08-14 | Journal article | Author
Contributors: Mert U; Adawy A; Scharff E; Teichmann P; Willms A; Verena Haselmann; Colmorgen C; Johannes Lemke; von Karstedt S; Juergen Fritsch et al.
Source: Self-asserted source
Anna Trauzold

Heterogeneous intracellular TRAIL-receptor distribution predicts poor outcome in breast cancer patients.

Journal of molecular medicine (Berlin, Germany)
2019-06-10 | Journal article
Contributors: Heilmann T; Vondung F; Dr. phil. Dipl.-Psych. Christoph Borzikowsky; Silke Szymczak; Krüger S; Alkatout I; Wenners A; Bauer M; Klapper W; Röcken et al.
Source: Self-asserted source
Anna Trauzold

The Hepatic Microenvironment and TRAIL-R2 Impact Outgrowth of Liver Metastases in Pancreatic Cancer after Surgical Resection.

Cancers
2019-05-29 | Journal article
Contributors: Miarka L; Hauser C; Helm O; Dörthe Holdhof; Beckinger S; Egberts JH; Gundlach JP; Lenk L; Rahn S; Wolfgang Mikulits et al.
Source: Self-asserted source
Anna Trauzold

Impact of p53 status on TRAIL-mediated apoptotic and non-apoptotic signaling in cancer cells.

PloS one
2019-04-04 | Journal article | Author
Contributors: Willms A; Schittek H; Rahn S; Justyna Sosna; Mert U; Dieter Adam; Anna Trauzold
Source: Self-asserted source
Anna Trauzold

TRAILblazing Strategies for Cancer Treatment.

Cancers
2019-03-30 | Journal article
Contributors: Kretz AL; Trauzold A; Hillenbrand A; Knippschild U; Henne-Bruns D; von Karstedt S; Johannes Lemke
Source: Self-asserted source
Anna Trauzold

Drug Repositioning Inferred from E2F1-Coregulator Interactions Studies for the Prevention and Treatment of Metastatic Cancers.

Theranostics
2019-02-20 | Journal article
Contributors: Goody D; Shailendra Gupta; Engelmann D; Spitschak A; Marquardt S; Mikkat S; Meier C; Hauser C; Gundlach JP; Egberts JH et al.
Source: Self-asserted source
Anna Trauzold

Downregulation of TRAIL-Receptor 1 Increases TGFβ Type II Receptor Expression and TGFβ Signalling Via MicroRNA-370-3p in Pancreatic Cancer Cells.

Cancers
2018-10-25 | Journal article
Contributors: Radke DI; Ling Q; Prof. Dr. Robert Häsler; Alp G; Ungefroren H; Trauzold A
Source: Self-asserted source
Anna Trauzold

The expression of death receptor systems TRAIL-R1/-R2/-R4, CD95 and TNF-R1 and their cognate ligands in pancreatic ductal adenocarcinoma.

Histology and histopathology
2018-10-24 | Journal article
Contributors: Gaertner F; Krüger S; Röder C; Trauzold A; Röcken; Kalthoff H
Source: Self-asserted source
Anna Trauzold

Cytoplasmic TRAIL-R1 is a positive prognostic marker in PDAC.

BMC cancer
2018-07-31 | Journal article | Author
Contributors: Gundlach JP; Hauser C; Schlegel FM; Böger C; Röder C; Röcken; Becker T; Egberts JH; Kalthoff H; Anna Trauzold
Source: Self-asserted source
Anna Trauzold

Identifying patients with an unfavorable prognosis in early stages of colorectal carcinoma.

Oncotarget
2018-06-08 | Journal article
Contributors: Hendricks A; Greta Lou Eggebrecht; Bernsmeier A; Geisen R; Dall K; Trauzold A; Becker T; Kalthoff H; Schafmayer C; Röder C et al.
Source: Self-asserted source
Anna Trauzold

The novel TRAIL-receptor agonist APG350 exerts superior therapeutic activity in pancreatic cancer cells.

Cell death & disease
2018-05-01 | Journal article
Contributors: Legler K; Hauser C; Egberts JH; Willms A; Heneweer C; Susann Boretius; Röcken; Glüer CC; Becker T; Kluge M et al.
Source: Self-asserted source
Anna Trauzold

Should We Keep Walking along the Trail for Pancreatic Cancer Treatment? Revisiting TNF-Related Apoptosis-Inducing Ligand for Anticancer Therapy.

Cancers
2018-03-18 | Journal article
Contributors: Kretz AL; von Karstedt S; Andreas Hillenbrand; Henne-Bruns D; Knippschild U; Trauzold A; Johannes Lemke
Source: Self-asserted source
Anna Trauzold

Tumor-reducing effect of the clinically used drug clofazimine in a SCID mouse model of pancreatic ductal adenocarcinoma.

Oncotarget
2017-06-01 | Journal article
Contributors: Zaccagnino A; Managò A; LUIGI LEANZA; Gontarewitz A; Linder B; Michele Azzolini; Lucia Biasutto; Zoratti M; Roberta Peruzzo; Legler K et al.
Source: Self-asserted source
Anna Trauzold

The prognostic relevance of primary tumor location in patients undergoing resection for pancreatic ductal adenocarcinoma.

Oncotarget
2017-02-01 | Journal article
Contributors: Ling Q; Xu X; Ye P; Xie H; Gao F; Hu Q; Liu Z; Wei X; Röder C; Trauzold A et al.
Source: Self-asserted source
Anna Trauzold

Pharmacologically Inactive Bisphosphonates as an Alternative Strategy for Targeting Osteoclasts: In Vivo Assessment of 5-Fluorodeoxyuridine-Alendronate in a Preclinical Model of Breast Cancer Bone Metastases.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
2016-11-07 | Journal article
Contributors: Schem C; Robert Tower; Kneissl P; Rambow AC; Campbell GM; Desel C; Damm T; Heilmann T; Fuchs S; Zuhayra M et al.
Source: Self-asserted source
Anna Trauzold

Differences and Similarities in TRAIL- and Tumor Necrosis Factor-Mediated Necroptotic Signaling in Cancer Cells.

Molecular and cellular biology
2016-09-26 | Journal article
Contributors: Sosna J; Philipp S; Fuchslocher Chico J; Saggau C; Juergen Fritsch; Föll A; Plenge J; Christoph Arenz; Pinkert T; Kalthoff H et al.
Source: Self-asserted source
Anna Trauzold

In silico analysis of the transportome in human pancreatic ductal adenocarcinoma.

European biophysics journal : EBJ
2016-09-21 | Journal article
Contributors: Angela Zaccagnino; Christian Pilarsky; Doaa Tawfik; Sebens S; Trauzold A; Ivana Novak; Schwab A; Kalthoff H
Source: Self-asserted source
Anna Trauzold

Negative control of TRAIL-R1 signaling by transforming growth factor β1 in pancreatic tumor cells involves Smad-dependent down regulation of TRAIL-R1.

Cellular signalling
2016-08-01 | Journal article
Contributors: Radke DI; Ungefroren H; Helm O; Voigt S; Alp G; Braun H; Hübner S; Dilchert J; Sebens S; Dieter Adam et al.
Source: Self-asserted source
Anna Trauzold

Effects of p38α/β inhibition on acute lymphoblastic leukemia proliferation and survival in vivo.

Leukemia
2015-06-24 | Journal article
Contributors: Alsadeq A; Strube S; Krause S; Carlet M; Irmela Jeremias; Vokuhl C; Loges S; Aguirre-Ghiso JA; Trauzold A; Cario G et al.
Source: Self-asserted source
Anna Trauzold
grade
Preferred source (of 2)‎

Cancer cell-autonomous TRAIL-R signaling promotes KRAS-driven cancer progression, invasion, and metastasis.

Cancer cell
2015-04-02 | Journal article
Contributors: von Karstedt S; Conti A; Max Nobis; Montinaro A; Hartwig T; Lemke J; Legler K; Annewanter F; Campbell AD; Taraborrelli L et al.
Source: Self-asserted source
Anna Trauzold

Proapoptotic and antiapoptotic proteins of the Bcl-2 family regulate sensitivity of pancreatic cancer cells toward gemcitabine and T-cell-mediated cytotoxicity.

Journal of immunotherapy (Hagerstown, Md. : 1997)
2015-04-01 | Journal article
Contributors: Christian Bauer; Hees C; Sterzik A; Bauernfeind F; Mak'Anyengo R; Peter Duewell; Lehr HA; Noessner E; Wank R; Trauzold A et al.
Source: Self-asserted source
Anna Trauzold

TRAIL-R2 promotes skeletal metastasis in a breast cancer xenograft mouse model.

Oncotarget
2015-04-01 | Journal article
Contributors: Fritsche H; Heilmann T; Robert Tower; Hauser C; von Au A; El-Sheikh D; Campbell GM; Alp G; Schewe D; Hübner S et al.
Source: Self-asserted source
Anna Trauzold

c-Rel is a critical mediator of NF-κB-dependent TRAIL resistance of pancreatic cancer cells.

Cell death & disease
2014-10-09 | Journal article
Contributors: Geismann C; Grohmann F; Sebens S; Wirths G; Dreher A; Prof. Dr. Robert Häsler; Philip Rosenstiel; Hauser C; Egberts JH; Trauzold A et al.
Source: Self-asserted source
Anna Trauzold

Compartmentalization of TNF-related apoptosis-inducing ligand (TRAIL) death receptor functions: emerging role of nuclear TRAIL-R2.

Cell death & disease
2014-08-28 | Journal article
Contributors: Bertsch U; Röder C; Kalthoff H; Trauzold A
Source: Self-asserted source
Anna Trauzold

TRAIL-induced programmed necrosis as a novel approach to eliminate tumor cells.

BMC cancer
2014-02-07 | Journal article
Contributors: Voigt S; Philipp S; Davarnia P; Winoto-Morbach S; Röder C; Christoph Arenz; Trauzold A; Kabelitz D; Schütze S; Kalthoff H et al.
Source: Self-asserted source
Anna Trauzold

Nuclear death receptor TRAIL-R2 inhibits maturation of let-7 and promotes proliferation of pancreatic and other tumor cells.

Gastroenterology
2013-10-09 | Journal article
Contributors: Verena Haselmann; Kurz A; Bertsch U; Hübner S; Olempska-Müller M; Juergen Fritsch; Prof. Dr. Robert Häsler; Pickl A; Fritsche H; Annewanter F et al.
Source: Self-asserted source
Anna Trauzold
grade
Preferred source (of 2)‎

TRAIL-induced expression of uPA and IL-8 strongly enhanced by overexpression of TRAF2 and Bcl-xL in pancreatic ductal adenocarcinoma cells.

Hepatobiliary & pancreatic diseases international : HBPD INT
2013-02-01 | Journal article
Contributors: Zhou DH; Yang LN; Roder C; Kalthoff H; Trauzold A
Source: Self-asserted source
Anna Trauzold

Impaired CK1 delta activity attenuates SV40-induced cellular transformation in vitro and mouse mammary carcinogenesis in vivo.

PloS one
2012-01-03 | Journal article
Contributors: Hirner H; Günes C; Bischof J; Wolff S; Grothey A; Kühl M; Oswald F; Wegwitz F; Bösl MR; Trauzold A et al.
Source: Self-asserted source
Anna Trauzold

Assessment of anti-inflammatory tumor treatment efficacy by longitudinal monitoring employing sonographic micro morphology in a preclinical mouse model.

BMC medical imaging
2011-06-23 | Journal article
Contributors: Tiwari S; Egberts JH; Korniienko O; Köhler L; Trauzold A; Glüer CC; Kalthoff H
Source: Self-asserted source
Anna Trauzold

Epicatechin gallate and catechin gallate are superior to epigallocatechin gallate in growth suppression and anti-inflammatory activities in pancreatic tumor cells.

Cancer science
2011-02-24 | Journal article
Contributors: Kürbitz C; Heise D; Torben Redmer; Goumas F; Alexander Arlt; Lemke J; Gerald Rimbach; Kalthoff H; Trauzold A
Source: Self-asserted source
Anna Trauzold

Impact of death receptor signaling on the malignancy of pancreatic ductal adenocarcinoma.

European journal of cell biology
2010-12-03 | Journal article
Contributors: Röder C; Trauzold A; Kalthoff H
Source: Self-asserted source
Anna Trauzold

Soluble and transmembrane TNF-like weak inducer of apoptosis differentially activate the classical and noncanonical NF-kappa B pathway.

Journal of immunology (Baltimore, Md. : 1950)
2010-07-07 | Journal article
Contributors: Roos C; Wicovsky A; Müller N; Salzmann S; Rosenthal T; Kalthoff H; Trauzold A; Seher A; Henkler F; Kneitz C et al.
Source: Self-asserted source
Anna Trauzold

Mutant PIK3CA licenses TRAIL and CD95L to induce non-apoptotic caspase-8-mediated ROCK activation.

Cell death and differentiation
2010-04-09 | Journal article
Contributors: Martin Ehrenschwender; Siegmund D; Wicovsky A; Michael Kracht; Dittrich-Breiholz O; Volker Spindler; Waschke J; Kalthoff H; Trauzold A; Harald Wajant
Source: Self-asserted source
Anna Trauzold

TRAIL signaling is mediated by DR4 in pancreatic tumor cells despite the expression of functional DR5.

Journal of molecular medicine (Berlin, Germany)
2010-03-31 | Journal article
Contributors: Lemke J; Noack A; Dieter Adam; Tchikov V; Bertsch U; Röder C; Schütze S; Harald Wajant; Kalthoff H; Trauzold A
Source: Self-asserted source
Anna Trauzold

Following the death TRAIL to hunt down tumor cells: translating programmed cell death signaling mechanisms into clinical practice.

Results and problems in cell differentiation
2009-01-01 | Journal article
Contributors: Kalthoff H; Trauzold A
Source: Self-asserted source
Anna Trauzold

Dexamethasone reduces tumor recurrence and metastasis after pancreatic tumor resection in SCID mice.

Cancer biology & therapy
2008-04-14 | Journal article
Contributors: Egberts JH; Schniewind B; Pätzold M; Kettler B; Tepel J; Kalthoff H; Trauzold A
Source: Self-asserted source
Anna Trauzold

The potential molecular mechanism of overexpression of uPA, IL-8, MMP-7 and MMP-9 induced by TRAIL in pancreatic cancer cell.

Hepatobiliary & pancreatic diseases international : HBPD INT
2008-04-01 | Journal article
Contributors: Zhou DH; Trauzold A; Röder C; Pan G; Zheng C; Kalthoff H
Source: Self-asserted source
Anna Trauzold

Anti-tumor necrosis factor therapy inhibits pancreatic tumor growth and metastasis.

Cancer research
2008-03-01 | Journal article
Contributors: Egberts JH; Cloosters V; Noack A; Schniewind B; Thon L; Klose S; Kettler B; von Forstner C; Kneitz C; Tepel J et al.
Source: Self-asserted source
Anna Trauzold
Items per page:
Page 1 of 2

Peer review (1 review for 1 publication/grant)

Review activity for Cell death and differentiation. (1)